GlassScriptPhysician profile
Tova Hecht
NPI 1992163992
$8,833.01
in general payments reported to CMS, 2019-2025
45 companies · $2,971 in 2025
The $2,971 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $1,240 · 2023: $1,906 · 2024: $2,568 · 2025: $2,971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,043 · Education: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,042.99 |
| Education | $402.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $776.62 | 2023-2025 | Enhertu, Datroway, Vanflyta |
| Lilly USA, LLC | $758.31 | 2022-2025 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $733.34 | 2023-2025 | Darzalex, Tecvayli, Talvey |
| Boehringer Ingelheim Pharmaceuticals, INC. | $603.98 | 2021-2025 | Jardiance, Gilotrif |
| Merck Sharp & Dohme LLC | $442.38 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Gilead Sciences, INC. | $398.78 | 2023-2025 | Trodelvy |
| Takeda Pharmaceuticals U.S.A., INC. | $374.52 | 2022-2025 | Ninlaro, Vpriv, Iclusig |
| Pfizer INC. | $351.08 | 2022-2025 | |
| Eisai INC. | $347.58 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $344.55 | 2022-2025 | Opdivo |
| Seagen INC. | $327.30 | 2022-2023 | Padcev, Tukysa |
| Astellas Pharma US INC | $312.67 | 2024-2025 | Vyloy |
| Abbvie INC. | $297.55 | 2022-2025 | |
| Incyte Corporation | $290.23 | 2023-2025 | Monjuvi, Zynyz, Pemazyre |
| Csl Behring | $269.75 | 2023-2024 | Kcentra |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tova Hecht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.